OTC: TCNNF - Trulieve Cannabis Corp.

Yield per half year: -54.91%
Dividend yield: 0.00%
Sector: Healthcare

Trulieve Cannabis Corp.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
115.83 31.52 267.53% 32.73 +253.95%
P/S 0.8906 3.23 -72.43%
P/BV 0.7139 3.36 -78.75%
P/FCF 4.95 21.22 -76.66%
Ev/Ebitda 10.91 9.93 9.88%
Ev/S 1.14 1.88 -39.52%
Ev/FCF 8.79 19.91 -55.83%
E/P -0.7267 1.47 -149.5%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
12.57 24.35 -48.38% 44.37 -71.67%
ROE -37.24 13.11 -384.02%
ROA -19.3 6.09 -416.74%
ROIC -0.92 15.56 -105.91%
ROS -46.65 12.44 -475.11%
ROCE 0 14.35 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
4/10
3.1 6.21 -50.17% 3.66 -15.39%
Nеt Debt/Ebitda 1.81 -5.72 -131.56%
Debt/Ratio 0.1769 0.213 -16.94%
Debt/Equity 0.8142 12.49 -93.48%
Debt/Net Income -0.9165 15.07 -106.08%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.76 -100% 0 0%
Number of years of dividend growth 0 1.21 -100%
DSI 0 0.7783 -100%
Average dividend growth 0 -269.81 -100%
Average percentage for 5 years 0 2.8 -100%
Average percentage for payments 0 246.95 -100%
Difference from average difference in sector -1.76

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
346.32 132.71 160.96%
Growth impulse Ebitda in 5 years -49.7 100.7 -149.35%
Growth impulse Net Income in 5 years -395.95 116.53 -439.78%
Growth impulse FCF in 5 years -386.96 88.28 -538.33%
Growth impulse EPS in 5 years -714.92 217.84 -428.19%
IP Score
3.53/10

Similar companies

Curaleaf Holdings, Inc.

Teligent, Inc.

Eisai Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription